Medtronic Incontinence Device Appears Set For Favorable MCAC Review
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's InterStim sacral nerve stimulation (SNS) device for urinary incontinence is apparently poised for the first favorable review by the Medicare Coverage Advisory Commission (MCAC), based on a technical assessment prepared by the Technology Evaluation Center (TEC) of the Blue Cross/Blue Shield Association.